drugset / Trial / NCT05310110

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

NCT05310110

Completed 96 enrolled Chang Gung Memorial Hospital
RandomizedFactorialTriple-blindOther

Summary

Laryngeal mask airway (LMA) is currently the most widely used supraglottic airway device with advantages of simple and fast placement, reduced anesthesia drug use, more stable hemodynamics, and less throat discomfort after anesthesia compared to endotracheal intubation. Some studies claimed the use of muscle relaxants or local anesthetics (sprays or lubricants containing local anesthetics) for the throat before LMA placement can reduce the dosage of induction agents and postoperative throat complications. In modern society, more and more elderly people undergo elective surgery with the need of general anesthesia. However, they are the more vulnerable population with tendency of greater hemodynamic changes with more induction agent usage. Propofol is one of the most used induction agents which may lead to a drop in blood pressure. The objective of this study is to observe whether the dose of propofol and the changes in hemodynamics can be reduced by using muscle relaxants or laryngeal local anesthetics in elderly who receiving general anesthesia with LMA insertion.

Timeline

Start
2022-04-12
Primary completion
2023-08-24
Completion
2023-08-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 0.12 mg/kg Intravenous
Subject Lidocaine Other / unclassified 10 % Other
Subject Propofol Small molecule 1 mg/kg Intravenous
Subject Propofol Small molecule 1.25 mg/kg Intravenous
Subject Propofol Small molecule 2 mg/kg Intravenous

Indications

No indication recorded.